Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial

被引:0
|
作者
Schreiber, S. [1 ]
Feagan, B. [2 ,3 ]
Peyrin-Biroulet, L. [4 ]
Vermeire, S. [5 ]
Faes, M. [6 ]
Harris, K. [7 ]
Oortwijn, A. [7 ]
Daniele, P. [8 ]
Patel, H. [6 ]
Danese, S. [9 ,10 ]
机构
[1] Univ Kiel, Dept Gen Internal Med, Kiel, Germany
[2] Alimentiv Inc, London, ON, Canada
[3] Western Western Univ, London Hlth Sci Ctr, Div Gastroenterol, London, ON, Canada
[4] Univ Lorraine, Univ Hosp Nancy, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[5] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
[6] Galapagos Nv, Mechelen, Belgium
[7] Galapagos Nv, Leiden, Netherlands
[8] Cytel Hlth, Toronto, ON, Canada
[9] Univ Vita Salute, San Raffaele, Milan, Italy
[10] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
来源
关键词
INFLAMMATORY-BOWEL-DISEASE;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OP07
引用
收藏
页码:I007 / I008
页数:3
相关论文
共 50 条
  • [21] Relationship between symptoms and health-related quality of life benefits in patients with carcinoid syndrome: Post-hoc analyses from TELESTAR
    Pavel, M.
    Cella, D.
    Beaumont, J. L.
    Hudgens, S.
    Marteau, F.
    Feuilly, M.
    Gabriel, S.
    Houchard, A.
    Ramage, J.
    Hoersch, D.
    Kulke, M. H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Effects of induction and maintenance therapy with risankizumab on health-related quality of life outcomes in patients with moderately to severely active ulcerative colitis: A post-hoc analysis of Phase 2b/3 trials
    Panes, J.
    Loftus, E. V., Jr.
    Armuzzi, A.
    Siegmund, B.
    Sands, B. E.
    Boland, B. S.
    Kalabic, J.
    Lai, J. H.
    Sharma, D.
    Remple, V.
    Gonzalez, Y. Sanchez
    Lindsay, J. O.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1585 - I1586
  • [23] The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
    Aniwan, Satimai
    Bruining, David H.
    Park, Sang Hyoung
    Al-Bawardy, Badr
    Kane, Sunanda, V
    Prabhu, Nayantara Coelho
    Kisiel, John B.
    Raffals, Laura E.
    Papadakis, Konstantinos A.
    Pardi, Darrell S.
    Tremaine, William J.
    Loftus, Edward V., Jr.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [24] Health-Related Quality-of-Life after Laparoscopic Gastric Bypass Surgery with or Without Closure of the Mesenteric Defects: a Post-hoc Analysis of Data from a Randomized Clinical Trial
    Erik Stenberg
    Eva Szabo
    Johan Ottosson
    Anders Thorell
    Ingmar Näslund
    Obesity Surgery, 2018, 28 : 31 - 36
  • [25] Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia
    Awad, George
    Hassan, Mariam
    Loebel, Antony
    Hsu, Jay
    Pikalov, Andrei
    Rajagopalan, Krithika
    BMC PSYCHIATRY, 2014, 14
  • [26] Health-Related Quality-of-Life after Laparoscopic Gastric Bypass Surgery with or Without Closure of the Mesenteric Defects: a Post-hoc Analysis of Data from a Randomized Clinical Trial
    Stenberg, Erik
    Szabo, Eva
    Ottosson, Johan
    Thorell, Anders
    Naslund, Ingmar
    OBESITY SURGERY, 2018, 28 (01) : 31 - 36
  • [27] Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia
    George Awad
    Mariam Hassan
    Antony Loebel
    Jay Hsu
    Andrei Pikalov
    Krithika Rajagopalan
    BMC Psychiatry, 14
  • [28] Etrolizumab demonstrated no difference among doses in symptomatic and endoscopic-based evaluation of remission in anti-TNF-α-naive patients in a post-hoc analysis of the phase 2 ulcerative colitis trial (EUCALYPTUS)
    Sandborn, W. J.
    Schreiber, S.
    Tang, M. T.
    Tatro, A. R.
    Oh, Y. S.
    Maciuca, R.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S278 - S279
  • [29] Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
    Kobayashi, T.
    Dignass, A.
    Roblin, X.
    Fujitani, Y.
    Oortwijn, A.
    Jamoul, C.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 459 - 460
  • [30] The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
    Strand, Vibeke
    Jayne, David R. W.
    Horomanski, Audra
    Yue, Huibin
    Bekker, Pirow
    Merkel, Peter A.
    LANCET RHEUMATOLOGY, 2023, 5 (08): : E451 - E460